9-78297272-T-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_058179.4(PSAT1):c.60+2T>C variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_058179.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSAT1 | NM_058179.4 | c.60+2T>C | splice_donor_variant, intron_variant | Intron 1 of 8 | ENST00000376588.4 | NP_478059.1 | ||
PSAT1 | NM_021154.5 | c.60+2T>C | splice_donor_variant, intron_variant | Intron 1 of 7 | NP_066977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSAT1 | ENST00000376588.4 | c.60+2T>C | splice_donor_variant, intron_variant | Intron 1 of 8 | 1 | NM_058179.4 | ENSP00000365773.3 | |||
PSAT1 | ENST00000347159.6 | c.60+2T>C | splice_donor_variant, intron_variant | Intron 1 of 7 | 1 | ENSP00000317606.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1447094Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 719914
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
PSAT1-related disorder Pathogenic:1
Variant summary: PSAT1 c.60+2T>C is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes the canonical 5' splicing donor site. One predict the variant no significant impact on splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 227624 control chromosomes. To our knowledge, no occurrence of c.60+2T>C in individuals affected with PSAT1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.